Kremoint Pharma Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 16-07-2024
- Paid Up Capital ₹ 0.60 M
as on 16-07-2024
- Company Age 32 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 6.01 Cr
as on 16-07-2024
- Satisfied Charges ₹ 33.29 Cr
as on 16-07-2024
- Revenue 103.32%
(FY 2023)
- Profit 85.93%
(FY 2023)
- Ebitda 72.62%
(FY 2023)
- Net Worth 40.28%
(FY 2023)
- Total Assets 38.44%
(FY 2023)
About Kremoint Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 0.60 M.
The company currently has active open charges totaling ₹6.01 Cr. The company has closed loans amounting to ₹33.29 Cr, as per Ministry of Corporate Affairs (MCA) records.
Bhadresh Thakkar, Vibha Sharma, and Gagan Harsh serve as directors at the Company.
- CIN/LLPIN
U24230MH1992PTC066737
- Company No.
066737
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 May 1992
- Date of AGM
17 Jul 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Ambernath, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Kremoint Pharma Private Limited offer?
Kremoint Pharma Private Limited offers a wide range of products and services, including Common Disease Medicines, Ointment, Cough Syrup, Industrial Chemicals & Supplies, Biocides, Hand Sanitizers & Personal Hygiene, Antiseptic Liquid & Cream, Skin Lightening Drugs, Cosmetics, Hair & Beauty Products, Skin Creams.
Who are the key members and board of directors at Kremoint Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bhadresh Thakkar  | Managing Director | 12-May-1992 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vibha Sharma | Director | 12-Jun-2020 | Current |
| Gagan Harsh | Director | 27-Jan-2022 | Current |
Financial Performance and Corporate Structure Insights of Kremoint Pharma.
Kremoint Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 103.32% increase. The company also saw a substantial improvement in profitability, with a 85.93% increase in profit. The company's net worth Soared by an impressive increase of 40.28%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kremoint Pharma?
In 2023, Kremoint Pharma had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Eipii Exports Private LimitedActive 10 years 26 daysBhadresh Thakkar and Gagan Harsh are mutual person
Eco Rich Cosmetic India Private LimitedActive 11 years 11 monthsBhadresh Thakkar is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 02 Feb 2024 | ₹5.00 Cr | Open |
Others Creation Date: 11 Jul 2023 | ₹0.10 M | Open |
Others Creation Date: 27 May 2023 | ₹1.00 Cr | Open |
How Many Employees Work at Kremoint Pharma?
Kremoint Pharma has a workforce of 121 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kremoint Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kremoint Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
